Clinical Trials Directory

Trials / Unknown

UnknownNCT01449604

Stereotactic Radiation in Vestibular Schwannoma

Randomized Comparison of Steretotactic Radiosurgery and Hypofractionated Steretotactic Radiotherapy in the Treatment of Vestibular Schwannoma

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Ramathibodi Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether stereotactic radiosurgery (SRS)and stereotactic radiotherapy (SRT)are effective in the treatment of vestibular schwannoma (VS).

Detailed description

Vestibular schwannomas (VSs) are slow-growing tumors of the myelin-forming cells that cover cranial nerve VIII.The treatment options for patients with VSs include active observation, surgical management, and radiotherapy. However, the optimal treatment choice remain controversial. Over the past 10 years, there has been rapid progress in the application of stereotactic radiotherapy to the treatment of VSs. The stereotactic radiotherapy program includes single fraction radiosurgery (SRS) and hypofraction stereotactic radiotherapy (HSRT) are commonly used for VSs treatment. Since SRS and SRT techniques differ significantly enough to raise questions of therapeutic advantage and until now, there is no prospective, randomized study comparing the outcomes for patients treated using both radiotherapy techniques. We designed the first prospective randomized protocol to compare SRS and SRT for answer this question.

Conditions

Interventions

TypeNameDescription
RADIATIONstereotactic radiotherapyStereotactic radiotherapy, hypofraction using 18 Gray in 3 fractions
RADIATIONstereotactic radiosurgeryRadio surgery 12 Gy

Timeline

Start date
2011-10-01
Primary completion
2013-10-01
Completion
2013-10-01
First posted
2011-10-10
Last updated
2011-10-10

Source: ClinicalTrials.gov record NCT01449604. Inclusion in this directory is not an endorsement.